The distinctive biology of cancer in adolescents and young adults

Nature Reviews Cancer

Volumn 8, Issue 4, 2008, Pages 288-298

  Bleyer, Archie ^a,b   Barr, Ronald ^c   Hayes Lattin, Brandon ^d   Thomas, David ^e   Ellis, Chad ^f   Anderson, Barry ^f  

^a ST CHARLES MEDICAL CENTER   (United States)

^b National Childhood Cancer Foundation   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; BREAST CANCER; CANCER REGISTRY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL RESEARCH; COLORECTAL CANCER; DATA BASE; EWING SARCOMA; HUMAN; LIVER CANCER; MELANOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA;

ADOLESCENT; ADULT; HUMANS; NEOPLASMS;

EID: 41149119450     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2349     Document Type: Review

References (59)

1. Schmidt, C. Lack of progress in teen and young adult cancers concerns researchers, prompts study. J. Natl Cancer Inst 98, 1760-1761 (2006).
2. Closing the gap: Research and care imperatives for adolescents and young adults with cancer. A report of the Adolescent and Young Adult Oncology Progress Review Group. Department of Health and Human Services, National Institutes of Health, National Cancer Institute and the LiveStrong Young Adult Alliance. National Cancer Institute [online], http://planning.cancer.gov/disease/ AYAO_PRG_Report_2006_FINAL.pdf (2006). The final report from the Progress Review Group convened by the National Institutes of Health to address the challenges of adolescent and young adult oncology.
3. Bleyer, A. Young adult oncology: The patients and their survival challenges. CA Cancer J. Clin. 57, 242-255 (2007). A recent overview of the particular issues faced by adolescents and young adults with cancer.
4. Bleyer, W. A., O'Leary, M., Barr, R. & Ries, L. A. G. (eds). Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival, 1975-2000. (National Cancer Institute, Bethesda, 2006). Also available at http://www.seer.cancer.gov/ publications/aya. The epidemiological foundation for the initiative in adolescent and young adult oncology in North America.
5. LiveStrong Young Adult Alliance. Closing the Gap: A Strategic Plan. Addressing the Recommendations of the Adolescent and Young Adult Progress Review Group. (Lance Armstrong Foundation, Austin 2007). The response from the Young Adult Alliance to the recommendations of the Progress Review Group, in the form of a strategic plan for implementation.
6. Nachman, J., Masera, G. & Bleyer, A. In Cancer in Adolescents and Young Adults (eds Bleyer, A., Barr, R. D., Albritton, K. H., Phillips, M. & Siegel, S.) 83-98 (Springer Verlag, Berlin Heidelburg New York, 2007). The first textbook dealing specifically and comprehensively with the topic of cancer in adolescents and young adults.
7. LaQuaglia, M. P. et al. Prognostic factors and outcome in patients 21 years and under with colorectal carcinoma. J. Pediatr. Surg. 27, 1085-1089 (1992).
8. Cotterill, S. J. et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J. Clin. Oncol. 18, 3108-3114 (2000).
9. Scurr, M. & Judson, I. How to treat the Ewing's family of sarcomas in adult patients. Oncologist 11, 65-72 (2006).
10. Verrill, M. W. et al. The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours. Ann. Oncol. 8, 1099-1105 (1997).
11. Paulussen, M. et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J. Clin. Oncol. 19, 1818-1829 (2001).
12. Grier, H. E. et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N. Engl. J. Med. 348, 694-701 (2003).
13. th Ann. Meeting Connective Tissue Oncol. Soc. 31 October-3 November 2008, Seattle, Washington, USA. Abstract 855.
14. Kalapurakal, J. A. et al. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group. Int. J. Radiat. Oncol. Biol. Phys. 60, 1379-1384 (2004).
15. Kushner, B. H., Kramer, K., LaQuaglia, MP., Modak, S. & Cheung, N. K. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Med. Pediatr. Oncol. 41, 508-515 (2003).
16. Ferrari, A. et al. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98, 571-580 (2003).
17. Anders, C. K. et al. Molecular signatures characterize early stage breast cancer arising in young women and have prognostic and therapeutic implications independent of ER status. J. Clin. Oncol. 25, 18S, 522a (2007).
18. Cleator, S., Heller, W. & Coombes, R. C. Triple-negative breast cancer: therapeutic options. Lancet Oncol. 8, 235-244 (2007).
19. Antoniou, A. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am. J. Hum. Genet. 72, 1117-1130 (2003).
20. Lalloo, F. et al. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives. Eur. J. Cancer 42, 1143-1150 (2006).
21. Anderson, W. F., Brinton, L. A., Chen, B. & Devesa, S. S. Qualitative age interactions (or effect modification) suggest divergent pathways for early-onset and late-onset breast cancers. J. Clin. Oncol. 25, 21036a (2007).
22. Rajagopalan, H., Nowak, M. A., Vogelstein, B. & Lengauer, C. The significance of unstable chromosomes in colorectal cancer. Nature Rev. Cancer 3, 695-701 (2003).
23. Popat, S., Hubner, R. & Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609-618 (2005).
24. Chiang, J. M. et al. Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis. Colon Rectum 46, 904-910 (2003).
25. Datta, R. V., LaQuaglia, M. P. & Paty, P. B. Genetic and phenotypic correlates of colorectal cancer in young patients. N. Engl. J. Med. 342, 137-138 (2000).
26. Kam, M. H., Eu, K. W., Barben, C. P. & Seow-Choen, F. Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis. 6, 191-194 (2004).
27. Al-Jaberi, T. M., Yaghan, R. J., El-Heis, H. A. Colorectal cancer in young patients under 40 years of age. Comparison with old patients in a well defined Jordanian population. Saudi Med. J. 8, 871-874 (2003).
28. Hill AD et al. Colorectal carcinoma in childhood and adolescence: A clinicopathological review. J. Clin. Oncol. 2007;25, 5808-5814.
29. Ferrari A et al. Colorectal carcinoma in children and adolescents: The experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr. Blood Cancer 50, 588-593 (2008).
30. Kanerva, J. et al. Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia. Med. Pediatr. Oncol. 33, 388-394 (1999).
31. Möricke, A. et al. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: Data from the Trials ALL-BFM 86, 90, and 95. Klin. Pädiatr 217, 310-320 (2005).
32. Hoelzer, D. Advances in the management of Ph-positive ALL. Clin. Adv. Hematol. Oncol. 4, 804-805 (2006).
33. Baldus, C. D. et al. High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J. Clin. Oncol. 24, 4714-4720 (2006).
34. Gutierrez, M. I., Siraj, A. K., Ibrahim, M. M., Hussain, A. & Bhatia, K. Childhood and adult ALL: differences in epigenetic lesions associated with cell cycle genes. Am. J. Hematol. 80, 158-160 (2005).
35. Stock, W. et al. Outcome of adolescents and young adults with ALL: A comparison of Children's Cancer Group and Cancer and Leukemia Group B Regimens. Blood 96, 467a (2000).
36. Boissel, N. et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J. Clin. Oncol. 21, 760-761 (2003).
37. de Bont, J. M. et al. Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia 18, 2032-2035 (2004).
38. Schroeder, H. et al. Prognosis of ALL in 10-20 year old patients in Denmark 1992-2001. Pediatr. Blood Cancer 45, 578a (2005).
39. Testi, A. et al. Difference in outcome of adolescents (14-17 years) with acute lymphoblastic leukaemia (ALL) enrolled in the Italian pediatric (AIEOP) an adult (GIMEMA) multicenter treatment protocols. J. Clin. Oncol. 24, 9024a (2006).
40. Ramanujachar, R. et al. Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr. Blood Cancer 48, 254-261 (2006).
41. Ramanujachar, R., Richards, S., Hann, I. & Webb, D. Adolescents with acute lymphoblastic leukaemia: Emerging from the shadow of paediatric and adult treatment protocols. Pediatr. Blood Cancer 43, 748-756 (2006).
42. Oschlies, I. et al. Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: A clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Münster) Multicenter Trial. Blood. 107, 4047-4052 (2006).
43. Hattinger, C. M. et al. Prognostic impact of chromosomal aberrations in Ewing tumours. Br. J. Cancer 86, 1763-1769 (2002).
44. Prakash, S. et al. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J. Pediatr. Hematol. Oncol. 27, 179-187 (2005).
45. Pappo, A. S., Helman, I. J. & Furman, W. L. Rare cancers in children: When adult tumors occur in children. ASCO 2006 Education Book (2006).
46. Prokurat, A. et al. Transitional liver cell tumors in older children and adolescents: A novel group of aggressive hepatic tumors expressing β-catenin. Med. Pediatr. Oncol. 39, 510-518 (2002).
47. Strouse, J. J., Fears, T. R., Tucker, M. A. & Wayne, A. S. Pediatric melanoma: risk factor and survival analysis of the Surveillance, Epidemiology and End Results Database. J. Clin. Oncol. 23, 4735-4741 (2005).
48. Lange, J. R., Palis, B. E., Chang, D. C., Soong, S. J. & Balch, C. M. Melanoma in children and teenagers: An analysis of patients from the National Cancer Data Base. J. Clin. Oncol. 25, 1363-1368 (2007).
49. T1799A(V600E) mutation in primary melanoma. J. Invest. Dermatol. 127, 900-905 (2007).
50. Lu, K. et al. Prospective determination of prevalence of Lynch Syndrome in young women with endometrial cancer. J. Clin. Oncol. 25, 5158-5164 (2007).
51. Butturini, A. M. et al. Obesity and outcome in pediatric acute lymphoblastic leukemia. J. Clin. Oncol. 25, 2063-2069 (2007).
52. Lange, B. J. et al. Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293, 203-211 (2005).
53. Haim, N. et al. Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas. Cancer 73, 2515-2519 (1994).
54. Roberson, J. R., Raju, S., Shelso, J., Pui, C. H. & Howard, S. C. Diabetic ketoacidosis during therapy for pediatric acute lymphoblastic leukemia. Pediatr. Blood Cancer. 11 Feb 2008 (doi:10.1002/pbc.21505).
55. Bürger, B. et al. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL) - experiences from trial ALL-BFM 95. Pediatr. Blood Cancer 49, 764.(2007).
56. Aricò, M. et al. Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia. Haematologica 88, 747-753 (2003).
57. Juergens, C et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO.-E.W.I.N.G. 99 clinical trial. Pediatr. Blood Cancer 47, 22-29 (2006).
58. Bleyer, A., Budd, T. & Montello, M. Adolescents and young adults with cancer: The scope of the problem and criticality of clinical trials. Cancer 107 (Suppl. 7), 1645-1655 (2006).
59. Barr, R. D., Holowaty, E. J., Birch, J. M. Classification schemes for tumors diagnosed in adolescents and young adults. Cancer 106, 1425-1430 (2006).